SCHEMBL7149409

SCHEMBL7149409

Cc1ccc(COc2ccc(OCc3ccc(C)cc3)c(C=C3SC(=S)N(C(Cc4ccccc4)C(=O)O)C3=O)c2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 1/20 0.68
MAPT P10636 6/20 0.67
POLB P06746 2/20 0.67
PLA2G1B P04054 1/20 0.67
ATG4B Q9Y4P1 1/20 0.67
PTPN1 P18031 8/20 0.64
PTPN2 P17706 1/20 0.62
PTPN6 P29350 1/20 0.62
CDC25B P30305 1/20 0.62
PTPN11 Q06124 1/20 0.62
BCL2 P10415 4/20 0.61
BCL2L2 Q92843 4/20 0.61
BAD Q92934 4/20 0.61
ALDH1A1 P00352 4/20 0.61
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
CRHBP P24387 1/20 0.61
CRHR2 Q13324 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
CTSL P07711 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7165592 0.94 MAPT (0.66) ADAMTS5MAPTPOLBPLA2G1BATG4B
SCHEMBL7146810 0.88 PTPN1 (0.54) ADAMTS5MAPTPOLBPLA2G1BATG4B
SCHEMBL7148425 0.83 ADAMTS5 (0.75) ADAMTS5MAPTPOLBPTPN1BCL2
SCHEMBL7140621 0.82 MAPT (0.68) ADAMTS5MAPTPOLBPTPN1PTPN2
SCHEMBL7149886 0.82 ADAMTS5 (0.65) ADAMTS5MAPTPOLBPTPN1BCL2
SCHEMBL7149430 0.82 PTPN1 (0.54) ADAMTS5MAPTPOLBPLA2G1BATG4B
SCHEMBL28506926 0.82 MAPT (0.70) ADAMTS5MAPTPOLBPLA2G1BATG4B
SCHEMBL28506925 0.82 MAPT (0.70) ADAMTS5MAPTPOLBPLA2G1BATG4B
SCHEMBL5218101 0.81 ADAMTS5 (1.00) ADAMTS5MAPTPOLBPLA2G1BATG4B
SCHEMBL6884103 0.81 ADAMTS5 (0.60) ADAMTS5MAPTPOLBPTPN1BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506755-B2 5-((2,4-bis-(4-methylphenylmethoxy)phenyl)methylene)-4-oxo-2-thioxo-3 -thiazolidineacetic acid, for example; treatment and prophylaxis of tumors and tumor metastasis HOFFMANN-LA ROCHE INC. 2003-01-14 US disclosed
US-20020037901-A1 Thiazolidinecarboxyl acids HOFFMANN-LA ROCHE INC. 2002-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020037901-A1 Thiazolidinecarboxyl acids TPMT, NAT1, THRA ADAMTS5 2515/4885MAPT 3924/4885POLB 3974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.